Dec 12 (Reuters) - The European Medicines Agency has recommended the approval of GSK's add-on drug to treat asthma and a chronic inflammatory sinus condition, the company said on Friday. The drug, ...

The European Medicines Agency’s (EMA) human medicines committee (CHMP) recommended five novel medicines for approval at its ...

ImmunityBio (NASDAQ: IBRX), a leading immunotherapy company, announced today that the European Medicines Agency has ...

EMA issues positive opinion on Novo Nordisk's higher-dose Wegovy, supported by strong weight-loss data and ongoing reviews in ...

Shares of ImmunityBio ticked higher after the company said the European Medicines Agency recommended granting a conditional marketing authorization for its treatment for non-muscle invasive bladder ...

The European Medicines Agency (EMA) has issued a positive opinion for a new Wegovy® 7.2 mg dose, advancing its availability ...

European legislators have reached a deal on a major rewrite of the region's pharma policies, pushing forward a framework ...

After years of winter medicine shortages, the European Medicines Agency told Euronews that there are currently no signs of antibiotic shortages, amid EU efforts to reduce dependency on foreign ...

Novo Nordisk A/S said its high-dose version of blockbuster Wegovy has been cleared by the European Union’s drug advisory board, opening the way for use of a shot that delivers more weight loss than ...

This press release was updated on 11 October 2023 to include the text of the provisional agreement. The presidency of the Council and European Parliament negotiators reached a provisional agreement on ...

The critical medicines act addresses shortages of key medicines to better meet patient needs and improve the EU’s resilience ...

Transparency, whether in politics, finance, or science, is a fundamental value of our society. In health care, decisions about medicines made by governments, regulators, and clinicians are, whenever ...